Fig. 8
From: circ-ANXA7 facilitates lung adenocarcinoma progression via miR-331/LAD1 axis
LAD1 is a prognostic marker for LUAD. a LAD1 immunohistochemistry staining intensity of LAD1 according to its scores. Magnification: ×40; ×200. b Immunohistochemistry of LAD1 between non-tumor and LUAD tissues. c Proportion of LAD1 immunohistochemistry staining intensity in TNM stage III & IV vs. I & II, in present distant metastasis vs. absent distant metastasis, in present recurrence vs. absent recurrence. d High LAD1 expression in LUAD tissues compared to non-tumor tissues among TCGA-LUAD cohort. e, f Overall survival and disease-free survival analysis of LAD1 expression for LUAD patients. *p < 0.05; **p < 0.01